Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 4 studies | 28% ± 10% | |
CD4-positive, alpha-beta T cell | 3 studies | 17% ± 1% | |
dendritic cell | 3 studies | 26% ± 9% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 25% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 2684.38 | 89 / 89 | 100% | 23.57 | 901 / 901 |
liver | 100% | 1447.24 | 226 / 226 | 100% | 22.55 | 406 / 406 |
pancreas | 100% | 2248.58 | 328 / 328 | 100% | 19.16 | 178 / 178 |
prostate | 100% | 3221.24 | 245 / 245 | 100% | 31.14 | 502 / 502 |
thymus | 100% | 3412.31 | 653 / 653 | 100% | 30.54 | 605 / 605 |
lung | 100% | 2509.28 | 578 / 578 | 100% | 23.28 | 1154 / 1155 |
skin | 100% | 3449.26 | 1809 / 1809 | 100% | 32.71 | 471 / 472 |
uterus | 100% | 4150.42 | 170 / 170 | 100% | 24.43 | 458 / 459 |
intestine | 100% | 3172.09 | 966 / 966 | 100% | 22.05 | 525 / 527 |
esophagus | 100% | 3052.88 | 1445 / 1445 | 99% | 13.95 | 182 / 183 |
stomach | 100% | 2741.03 | 359 / 359 | 99% | 18.75 | 284 / 286 |
breast | 100% | 3364.05 | 459 / 459 | 99% | 30.94 | 1110 / 1118 |
brain | 99% | 1227.34 | 2623 / 2642 | 100% | 18.54 | 705 / 705 |
ovary | 100% | 4406.12 | 180 / 180 | 99% | 22.38 | 426 / 430 |
bladder | 100% | 3181.95 | 21 / 21 | 99% | 23.27 | 499 / 504 |
adrenal gland | 100% | 3085.60 | 258 / 258 | 99% | 15.81 | 227 / 230 |
adipose | 100% | 3205.83 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 3075.56 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 32.70 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 34.30 | 29 / 29 |
muscle | 100% | 2643.41 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2390.61 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 21.65 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 16.37 | 1 / 1 |
heart | 99% | 1530.05 | 851 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 92% | 2161.59 | 852 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0001731 | Biological process | formation of translation preinitiation complex |
GO_0075522 | Biological process | IRES-dependent viral translational initiation |
GO_0006886 | Biological process | intracellular protein transport |
GO_0032790 | Biological process | ribosome disassembly |
GO_0016604 | Cellular component | nuclear body |
GO_0005829 | Cellular component | cytosol |
GO_0022627 | Cellular component | cytosolic small ribosomal subunit |
GO_0005737 | Cellular component | cytoplasm |
GO_0003743 | Molecular function | translation initiation factor activity |
GO_0038023 | Molecular function | signaling receptor activity |
GO_0003723 | Molecular function | RNA binding |
Gene name | EIF2D |
Protein name | Eukaryotic translation initiation factor 2D (eIF2d) (Hepatocellular carcinoma-associated antigen 56) (Ligatin) Eukaryotic translation initiation factor 2D |
Synonyms | LGTN HCA56 |
Description | FUNCTION: Translation initiation factor that is able to deliver tRNA to the P-site of the eukaryotic ribosome in a GTP-independent manner. The binding of Met-tRNA(I) occurs after the AUG codon finds its position in the P-site of 40S ribosomes, the situation that takes place during initiation complex formation on some specific RNAs. Its activity in tRNA binding with 40S subunits does not require the presence of the aminoacyl moiety. Possesses the unique ability to deliver non-Met (elongator) tRNAs into the P-site of the 40S subunit. In addition to its role in initiation, can promote release of deacylated tRNA and mRNA from recycled 40S subunits following ABCE1-mediated dissociation of post-termination ribosomal complexes into subunits. . |
Accessions | ENST00000367114.7 [P41214-2] A0A087X1L6 ENST00000484492.5 ENST00000271764.7 [P41214-1] ENST00000437518.1 ENST00000613435.1 Q5SY38 A0A087X202 ENST00000472709.6 P41214 A0A087WVB6 |